Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ)
CNY 12.29
(-0.32%)
CNY 12.29
(-0.32%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.93 Billion CNY | -1.33% |
| 2022 | 1.95 Billion CNY | 43.63% |
| 2021 | 1.36 Billion CNY | 18.64% |
| 2020 | 1.14 Billion CNY | -16.22% |
| 2019 | 1.37 Billion CNY | 6.08% |
| 2018 | 1.29 Billion CNY | 14.9% |
| 2017 | 1.12 Billion CNY | 40.5% |
| 2016 | 801.22 Million CNY | -34.57% |
| 2015 | 1.22 Billion CNY | 200.39% |
| 2014 | 407.62 Million CNY | 71.24% |
| 2013 | 238.03 Million CNY | 58.25% |
| 2012 | 150.41 Million CNY | 62.55% |
| 2011 | 92.53 Million CNY | -3.13% |
| 2010 | 95.53 Million CNY | -11.92% |
| 2009 | 108.45 Million CNY | -23.9% |
| 2008 | 142.52 Million CNY | -14.74% |
| 2007 | 167.17 Million CNY | 9.32% |
| 2006 | 152.92 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 1.27 Billion CNY | -5.21% |
| 2024 Q2 | 1.34 Billion CNY | -18.22% |
| 2024 Q1 | 1.64 Billion CNY | -14.78% |
| 2023 Q4 | 1.93 Billion CNY | 3.9% |
| 2023 Q1 | 1.78 Billion CNY | -9.04% |
| 2023 FY | 1.93 Billion CNY | -1.33% |
| 2023 Q3 | 1.86 Billion CNY | 7.44% |
| 2023 Q2 | 1.73 Billion CNY | -2.83% |
| 2022 Q2 | 1.73 Billion CNY | 12.48% |
| 2022 Q1 | 1.54 Billion CNY | 13.24% |
| 2022 Q3 | 2.11 Billion CNY | 22.02% |
| 2022 FY | 1.95 Billion CNY | 43.63% |
| 2022 Q4 | 1.95 Billion CNY | -7.59% |
| 2021 Q4 | 1.36 Billion CNY | 28.43% |
| 2021 Q1 | 1.13 Billion CNY | -1.44% |
| 2021 FY | 1.36 Billion CNY | 18.64% |
| 2021 Q3 | 1.06 Billion CNY | -10.66% |
| 2021 Q2 | 1.18 Billion CNY | 4.9% |
| 2020 Q2 | 1.35 Billion CNY | -14.54% |
| 2020 Q4 | 1.14 Billion CNY | -12.72% |
| 2020 Q3 | 1.31 Billion CNY | -2.7% |
| 2020 Q1 | 1.58 Billion CNY | 15.44% |
| 2020 FY | 1.14 Billion CNY | -16.22% |
| 2019 Q4 | 1.37 Billion CNY | 12.8% |
| 2019 FY | 1.37 Billion CNY | 6.08% |
| 2019 Q3 | 1.21 Billion CNY | -23.39% |
| 2019 Q2 | 1.58 Billion CNY | -3.83% |
| 2019 Q1 | 1.65 Billion CNY | 27.64% |
| 2018 Q3 | 1.27 Billion CNY | 24.71% |
| 2018 Q4 | 1.29 Billion CNY | 1.67% |
| 2018 FY | 1.29 Billion CNY | 14.9% |
| 2018 Q1 | 1.26 Billion CNY | 12.62% |
| 2018 Q2 | 1.02 Billion CNY | -19.54% |
| 2017 Q1 | 767.14 Million CNY | -4.25% |
| 2017 FY | 1.12 Billion CNY | 40.5% |
| 2017 Q4 | 1.12 Billion CNY | 23.79% |
| 2017 Q3 | 909.4 Million CNY | 36.25% |
| 2017 Q2 | 667.43 Million CNY | -13.0% |
| 2016 Q2 | 883.12 Million CNY | -25.69% |
| 2016 Q1 | 1.18 Billion CNY | -2.95% |
| 2016 FY | 801.22 Million CNY | -34.57% |
| 2016 Q4 | 801.22 Million CNY | -7.86% |
| 2016 Q3 | 869.56 Million CNY | -1.54% |
| 2015 Q3 | 1.07 Billion CNY | -11.7% |
| 2015 Q2 | 1.21 Billion CNY | 228.88% |
| 2015 FY | 1.22 Billion CNY | 200.39% |
| 2015 Q1 | 369.31 Million CNY | -9.4% |
| 2015 Q4 | 1.22 Billion CNY | 14.17% |
| 2014 Q1 | 225.76 Million CNY | -5.15% |
| 2014 Q4 | 407.62 Million CNY | 47.98% |
| 2014 Q3 | 275.45 Million CNY | -5.15% |
| 2014 FY | 407.62 Million CNY | 71.24% |
| 2014 Q2 | 290.4 Million CNY | 28.63% |
| 2013 Q2 | 150.92 Million CNY | -4.66% |
| 2013 Q3 | 157.98 Million CNY | 4.68% |
| 2013 FY | 238.03 Million CNY | 58.25% |
| 2013 Q1 | 158.29 Million CNY | 5.24% |
| 2013 Q4 | 238.03 Million CNY | 50.67% |
| 2012 Q3 | 112.57 Million CNY | 2.51% |
| 2012 Q4 | 150.41 Million CNY | 33.62% |
| 2012 FY | 150.41 Million CNY | 62.55% |
| 2012 Q1 | 103.18 Million CNY | 11.5% |
| 2012 Q2 | 109.81 Million CNY | 6.43% |
| 2011 Q2 | 109.91 Million CNY | 7.83% |
| 2011 Q4 | 92.53 Million CNY | 15.4% |
| 2011 Q3 | 80.18 Million CNY | -27.05% |
| 2011 FY | 92.53 Million CNY | -3.13% |
| 2011 Q1 | 101.93 Million CNY | 6.7% |
| 2010 Q2 | 75.57 Million CNY | -6.53% |
| 2010 Q3 | 77.15 Million CNY | 2.08% |
| 2010 Q1 | 80.85 Million CNY | -25.45% |
| 2010 Q4 | 95.53 Million CNY | 23.82% |
| 2010 FY | 95.53 Million CNY | -11.92% |
| 2009 Q2 | 151.6 Million CNY | 0.0% |
| 2009 Q3 | 123.87 Million CNY | -18.29% |
| 2009 Q4 | 108.45 Million CNY | -12.45% |
| 2009 FY | 108.45 Million CNY | -23.9% |
| 2008 FY | 142.52 Million CNY | -14.74% |
| 2008 Q4 | 142.52 Million CNY | 0.0% |
| 2007 FY | 167.17 Million CNY | 9.32% |
| 2006 FY | 152.92 Million CNY | 0.0% |